Content about Patent law

February 6, 2013

Reports: Senators introduce bill to ban 'pay-for-delay' settlements

Republican and Democratic senators have re-introduced legislation that would ban patent settlements between branded and generic drug companies that critics allege violate antitrust laws, according to published reports.

September 18, 2012

Record patent expirations roil Rx market

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals.

August 30, 2010

Salix settles MoviPrep patent dispute with Novel

Salix Pharmaceuticals announced its agreement with Novel Labs to settle its patent litigation over Novel’s...